HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 27 filers reported holding HORIZON PHARMA INVT LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $32,452,000 | +5.1% | 32,187,000 | +0.3% | 0.99% | +3.7% |
| Q2 2018 | $30,888,000 | +36.0% | 32,106,000 | +30.5% | 0.95% | +76.8% |
| Q1 2018 | $22,706,000 | -33.1% | 24,606,000 | -32.8% | 0.54% | -46.4% |
| Q4 2017 | $33,930,000 | +58.5% | 36,606,000 | +55.1% | 1.00% | +32.1% |
| Q3 2017 | $21,403,000 | +4.7% | 23,606,000 | 0.0% | 0.76% | -11.9% |
| Q2 2017 | $20,448,000 | -11.0% | 23,606,000 | -6.0% | 0.86% | +0.9% |
| Q1 2017 | $22,975,000 | +270.6% | 25,106,000 | +286.8% | 0.85% | +252.9% |
| Q4 2016 | $6,199,000 | -81.2% | 6,491,000 | -80.9% | 0.24% | -84.0% |
| Q3 2016 | $33,040,000 | +16.1% | 33,991,000 | +9.3% | 1.51% | +21.2% |
| Q2 2016 | $28,448,000 | – | 31,091,000 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 136,032,000 | $150,514,000 | 5.41% |
| SYMPHONY ASSET MANAGEMENT LLC | 16,000,000 | $17,780,000 | 3.72% |
| CSS LLC/IL | 12,427,000 | $13,791,000 | 0.79% |
| SSI INVESTMENT MANAGEMENT LLC | 8,793,000 | $9,740,000 | 0.72% |
| Worth Venture Partners, LLC | 1,103,000 | $1,227,000 | 0.68% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,900,000 | $33,208,000 | 0.64% |
| Sonora Investment Management, LLC | 4,840,000 | $5,374,000 | 0.60% |
| Empyrean Capital Partners, LP | 8,000,000 | $8,875,000 | 0.40% |
| DLD Asset Management, LP | 5,500,000 | $6,129,000 | 0.26% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 12,500 | $10,496,000 | 0.25% |